Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To compare the overall survival (OS) in subjects with R/M HNSCC treated with pembrolizumab compared to standard treatment.
Critère d'inclusion
- Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma